T1	Intervention 14 21	placebo
T2	Intervention 50 59	ganitumab
T3	Intervention 63 74	conatumumab
T4	Intervention 139 172	KRAS metastatic colorectal cancer
T5	Intervention 226 266	mutant KRAS metastatic colorectal cancer
T6	Intervention 278 289	bevacizumab
T7	Intervention 294 305	aflibercept
T8	Intervention 429 438	ganitumab
T9	Intervention 442 452	monoclonal
T10	Intervention 474 488	type 1 insulin
T11	Intervention 363 392	agonistic monoclonal antibody
T12	Intervention 347 358	conatumumab
T13	Intervention 541 561	FOLFIRI chemotherapy
T14	Intervention 613 622	KRAS mCRC
T15	Intervention 734 751	fluoropyrimidine-
T16	Intervention 756 786	oxaliplatin-based chemotherapy
T17	Intervention 824 843	intravenous FOLFIRI
T18	Intervention 849 860	conatumumab
T19	Intervention 879 888	ganitumab
T20	Intervention 910 917	placebo
T21	Intervention 1398 1409	neutropenia
T22	Intervention 1428 1436	diarrhea
T23	Intervention 1484 1493	ganitumab
T24	Intervention 1463 1474	Conatumumab
T25	Intervention 1500 1507	FOLFIRI
T26	Intervention 1552 1555	PFS
